Localized morphoea, xanthomatosis and primary biliary cirrhosis [6]

British Journal of Dermatology

Volumn 143, Issue 3, 2000, Pages 652-653

  Reed, J R ^a   De Luca, N ^b   McIntyre, A S ^b   Wilkinson, J D ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

^b WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; COLESTYRAMINE; URSODEOXYCHOLIC ACID;

ADULT; AUTOIMMUNE DISEASE; BILIARY CIRRHOSIS; CASE REPORT; CLINICAL FEATURE; HUMAN; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; LOW FAT DIET; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; XANTHOMATOSIS;

ADULT; AUTOIMMUNE DISEASES; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; SCLERODERMA, LOCALIZED; XANTHOMATOSIS;

EID: 0033801742     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03732.x     Document Type: Letter

References (8)

1. An investigation into the incidence of auto-immune disorders in patients with localized morphoea
2. Anti-histone antibodies in localized scleroderma
3. Scleroderma-like changes due to chronic graft-versus-host disease
4. Is primary biliary cirrhosis an autoimmune disease?
5. Hypercholesterolaemia and atherosclerosis in primary biliary cirrhosis: What is the risk?
6. Hypercholesterolaemia in primary biliary cirrhosis is no risk factor for atherosclerosis
7. Generalised morphoea, lichen sclerosus et atrophicus and primary biliary cirrhosis
8. Generalized morphoea and primary biliary cirrhosis: A rare association and improvement with oxpentifylline